As genetic testing becomes more complex, the need for education continues to grow. Our webinar series, “Noninvasive Prenatal Testing: Background, Science, and Clinical Implementation,” was developed to help you propel progress in reproductive and genetic health. These modules are designed to be watched at your own pace. Holly Snyder, MS, CGC, a Senior Genetic Counselor at Illumina, walks through an overview of screening terminology and available aneuploidy testing options. Webinar at a glance • Provides basic understanding of screening terminology • Reviews current prenatal aneuploidy screening and testing options available with an introduction to the goals of NIPT • Walks through case examples that demonstrate how differences in a priori risk or test performance impact positive predictive value of a screening test Presenter: Holly Snyder, MS, CGC View related webinars NIPT for All Pregnancies? A Discussion with Larry Platt, MD https://illuminainc.adobeconnect.com/_a1083004425/p23jpy1q68g/?launcher=false&fcsContent=true&pbMode=normal View related videos Integrating Non-invasive DNA Testing (NIDT) into the Prenatal Testing Paradigm: Diana W. Bianchi, MD https://www.youtube.com/embed/BWd9WNZ_3QM?iframe&rel=0&autoplay=1 View related article Taneja PA, Snyder HL, de Feo E, et al. Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85,000 cases. Prenat Diagn. 2015;doi:10.1002/pd.4766. http://onlinelibrary.wiley.com/doi/10.1002/pd.4766/abstract?campaign=wolacceptedarticle Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc